Differential effect of isotype on efficacy of anti-tumor necrosis factor alpha chimeric antibodies in experimental septic shock.
Amanda Suitters(UCB Pharma (United Kingdom)), L Chaplin, Sue Stephens(Cleveland Clinic), Alex Holt(UCB Pharma (United Kingdom)), Roly Foulkes(UCB Pharma (United Kingdom)), Mark W. Rolfe(UCB Pharma (United Kingdom)), Jean Palardy, A Morgan(UCB Pharma (United Kingdom)), J.S. Emtage, Steven M. Opal(Brown University)
Cited by 67
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
|Critical Care Medicine|2003|6k
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
|Intensive Care Medicine|2003|2.9k